Trident Lifeline Limited
TLL (BSE 543616) · ISIN INE0MKA01014 · Pharmaceuticals · Est. 2014 · listed 2022 · website
Not on any surveillance list
In Q1 FY27 (quarter to 30 June 2026, consolidated), revenue was ₹33.72 cr and profit after tax ₹5.07 cr.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 consolidated | ₹33.72 cr | ₹5.07 cr | 4.27 | 29 Jul 2026 |
| Q3 FY26 consolidated | ₹25.71 cr | ₹4.65 cr | 3.72 | 17 Jan 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2026 standalone | ₹111.16 cr | ₹42.31 cr | ₹174.57 cr |
| 31 Mar 2026 standalone | ₹99.08 cr | ₹24.59 cr | ₹159.19 cr |
| 30 Sep 2025 standalone | ₹76.62 cr | ₹20.72 cr | ₹129.18 cr |
Latest filings
- Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting .... 29 October 2026 · BSE
- Further to our letter dated 05th October, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), .... 27 October 2026 · BSE
- The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone and Consolidated Financial Results for the half year ended 30th September, 2026. (The copy of Un-Audited .... 26 October 2026 · BSE
- Outcome of Board Meeting held on 26.10.2026 26 October 2026 · BSE
- Trident Lifeline Limited has issued corrigendum to the Notice of EOGM 16 October 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.